Literature DB >> 2444031

Molecular characterization of a polymerase mutant human immunodeficiency virus.

H E Gendelman1, T S Theodore, R Willey, J McCoy, A Adachi, R J Mervis, S Venkatesan, M A Martin.   

Abstract

A cell line (8E5) containing a single defective copy of human immunodeficiency virus proviral DNA and producing noninfectious viral particles lacking reverse transcriptase (RT) and endonuclease proteins has recently been described (Folks, et al., (1986b) J. Exp. Med. 164, 280-290). In this report, the mutation in a full-length molecular clone of the provirus (p8E5) was mapped to a 1931-bp region of the pol gene encoding RT. The nucleotide sequence of this segment revealed a 1-base deletion 301 codons from the common amino terminus of the 64- and 51-kDa RTs. Expression of the p8E5 RT segment in Escherichia coli generated an enzymatically inactive and truncated 33-kDa protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2444031     DOI: 10.1016/0042-6822(87)90002-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

2.  Genetic recombination of human immunodeficiency virus.

Authors:  F Clavel; M D Hoggan; R L Willey; K Strebel; M A Martin; R Repaske
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression.

Authors:  N J Besansky; S T Butera; S Sinha; T M Folks
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  A defective proviral DNA with a 2.6-kb deletion of human immunodeficiency virus type 1 (HIV-1) in a persistently HIV-1 infected cell clone.

Authors:  H Imai; K Maotani-Imai; Y S Shin; K Ikuta; S Suehiro; T Kurimura; S Kato; K Hirai
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

5.  3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.

Authors:  R W Buckheit; J Germany-Decker; K Qualls-Goodwin; B J Bowdon; W M Shannon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

6.  HIV-1 transforms the monocyte plasma membrane proteome.

Authors:  Irena Kadiu; Tong Wang; Joshua D Schlautman; Larisa Dubrovsky; Pawel Ciborowski; Michael Bukrinsky; Howard E Gendelman
Journal:  Cell Immunol       Date:  2009-04-08       Impact factor: 4.868

7.  Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells.

Authors:  F Boulerice; X G Li; A Lvovich; M A Wainberg
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  Field evaluation of Abbott Real Time HIV-1 Qualitative test for early infant diagnosis using dried blood spots samples in comparison to Roche COBAS Ampliprep/COBAS TaqMan HIV-1 Qual test in Kenya.

Authors:  Joy Chang; Kenneth Omuomo; Emily Anyango; Leonard Kingwara; Frank Basiye; Alex Morwabe; Vedapuri Shanmugam; Shon Nguyen; Jennifer Sabatier; Clement Zeh; Dennis Ellenberger
Journal:  J Virol Methods       Date:  2014-04-13       Impact factor: 2.014

9.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus.

Authors:  E P Lillehoj; F H Salazar; R J Mervis; M G Raum; H W Chan; N Ahmad; S Venkatesan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.